Telitacicept 
RemeGen
['lupus', 'telitacicept']
dr. van vollenhoven presents telitacicept data in #sle (phase iii): significant higher sri-4 response lowered the risk of flare/severe flare not increase infection risk clinical benefits and favorable safety profile in moderate/severe #lupus #eular2023 
MD, PhD candidate | Ready to learn about #Lupus #SLE and #AutoimmuneDiseases